EPIS_B: Record Q1 sales and US growth position Episurf for accelerated expansion and improved results

About this update from Episurf Medical Ab Class B

Episurf Medical delivered record Q1 sales and order intake, improved cost control, and a reduced loss, driven by US and European expansion. Strategic partnerships and a growing customer base support the goal of doubling sales annually to reach cash flow positivity. Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Episurf Medical Ab Class B